INTRODUCTION
============

Unlike conventional T cells, some T cells develop a memory-like phenotype in the thymus and immediately respond upon antigen stimulation. These T cells, termed innate CD8 T cells, include NKT cells, T-T CD4 (or T-CD4) T cells, H2-M3 specific T cells, mucosal-associated invariant T (MAIT) cells, CD8αα ^+^ intraepithelial T cells, and innate CD8 T cells expressing Eomesodermin (Eomes) ([@B1][@B2][@B3]).

Eomes ^+^ innate CD8 T cells were initially discovered in mice deficient in T cell signaling molecules or transcription factors such as *Itk*, *Klf2*, *Cbp*, or *Id3* ([@B3][@B4][@B5]). A large fraction of CD8 single positive (SP) thymocytes in these mice expresses memory markers such as CD44 and CD122, and IFN-γ. These cells expressed significant amounts of Eomes, which is dependent on the IL-4 produced by innate T cells expressing PLZF (promyelocytic leukemia zinc finger protein) ([@B4][@B6]). For this reason, these innate T cells were called IL-4-induced innate CD8 T cells ([@B7]). Eomes ^+^ innate CD8 T cells were also identified in CIITA transgenic (CIITA^Tg^) mice ([@B3]) and wild-type (WT) BALB/c mice ([@B6]). In plck-CIITA^Tg^ C57BL/6 (B6) mice, where the proximal lck promoter-driven expression of CIITA (MHC class II transactivator) induced the expression of major MHC class II in thymocytes and T cells, MHC class II dependent thymocyte-thymocyte (T-T) interactions allowed the generation of an innate CD4 T cell, called T-T CD4 T cells ([@B8]). High quantities of Eomes ^+^ CD8 T cells were detected in the thymus of these CIITA^Tg^ mice. The development of these cells was dependent on PLZF ^+^ T-T CD4 T cells ([@B9]), while PLZF ^+^ NKT cells drove the generation of these innate CD8 T cells in WT BALB/c mice ([@B6]). An Eomes ^+^ CD8 T cell population with an innate phenotype was also found in human fetal thymus and spleen ([@B9]).

In addition to innate CD8 T cell generation in an IL-4 rich intrathymic environment, similar cells have also been found in peripheral tissues of WT mice ([@B10][@B11]). Using MHC/peptide tetramers, a subpopulation of antigen-specific CD8 T cells bearing memory markers such as CD44, CD122, and Ly6C were found in unimmunized mice ([@B10]). Their presence in germ-free mice supported the hypothesis that these cells acquired a memory-like phenotype even in the absence of antigen stimulation. These antigen-inexperienced memory phenotype CD8 T cells have been called virtual memory (VM) CD8 T cells ([@B10][@B11][@B12]). Generation of VM CD8 T cells is dependent on endogenous IL-4 ([@B11]).

The memory-like CD8 T cell population is also expanded in mice administered with an IL-4/anti-IL-4 antibody complex (IL-4C) ([@B13]). IL-4C induces an innate CD8 T cell-like phenotype in peripheral CD8 T cells, which is characterized by elevated expression levels of CD44, CD122, CXCR3, and Eomes. However, the relationship between these three types of memory-like CD8 T cells (Eomes ^+^ innate CD8 T cells, VM CD8 T cells, and IL-4-induced memory-like CD8 T cells) has not been clearly documented. In the present study, IL-4-induced memory-like CD8 T cells were compared with innate CD8 T cell in terms of their phenotype and function.

MATERIALS AND METHODS
=====================

Mice
----

B6, BALB/c, IL-4 ^-/-^ B6, OT-I B6, and CD45.1 ^+^ B6 mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA). B6 mice were thymectomized at 6 weeks of age and maintained until 8 weeks of age. plck-CIITA^Tg^ mice were generated in the Seoul National University College of Medicine ([@B8]). All mice were bred and maintained under specific pathogen-free conditions in the Biomedical Center for Animal Resource Development at the Seoul National University. All experiments were approved by the Institutional Animal Care and Use Committee of the Institute of Laboratory Animal Resource at the Seoul National University, Korea.

Administration of IL-4 and anti-IL-4 antibody *in vivo*
-------------------------------------------------------

Based on a previously reported protocol ([@B14]), a mixture of 1.5 µg mouse IL-4 (Peprotech, Princeton, NJ, USA) and 50 µg anti-IL-4 antibody (11B11; Bio X Cell, West Lebanon, NH, USA) was intraperitoneally injected into mice daily. After 7 days of treatment, lymphoid organs were analyzed. For the adoptive transfer, donor CD8 T cells were isolated from CD45.1 ^+^ B6 mouse splenocytes using anti-CD8 microbeads and magnetic sorting (MACS; Miltenyi Biotec, Auburn, CA, USA). Next, these CD8 T cells were sorted into CD44^low^CXCR3 ^-^ and CD44^hi^CXCR3 ^+^ populations using a FACSAria (BD Bioscience, San Jose, CA, USA) and then labeled with Cell Trace Violet (CTV, Life Technologies, Waltham, MA, USA) for tracing. Each recipient B6 mouse received 3×10^6^ sorted cells via lateral tail vein injection, followed by IL-4C treatment one day later.

Flow cytometry analysis
-----------------------

Fluorochrome-or biotin-labeled monoclonal antibodies against the following antigens: CD8 (53-6.7), CD44 (IM7), CD62L (MEL-14), CD124 (mIL4R-M1), CXCR3 (CXCR3-173), and CD24 (M1/69) were purchased from BD Bioscience (San Jose, CA, USA), eBioscience (San Diego, CA, USA), and BioLegend (San Diego, CA, USA). Single-cell suspensions were labeled with antibodies for 30 min at 4℃. For intracellular labeling, prepared cells were resuspended in a mixture of fixation and permeabilization buffers from the Foxp3 staining buffer kit (eBioscience, San Diego, CA, USA). Then, intracellular labeling was performed using antibody Eomes (BD Bioscience, San Diego, CA, USA). Flow cytometry was performed on a FACSCalibur and LSR Fortessa (Becton Bioscience, Mountain View, CA, USA). The data were analyzed using the FlowJo software (TreeStar, Ashland, OR, USA).

For the intracellular cytokine assay, CD8 T cells isolated from mouse spleens were stimulated with 50 ng/mL phorbol 12-myristate 13-acetate (PMA) and 1.5 µM ionomycin (Sigma-Aldrich, St Louis, MO, USA) for 4 h at 37℃ in a CO2 incubator, followed by an additional incubation in the presence of 10 µg/mL brefeldin A (Sigma-Aldrich, St Louis, MO, USA) for 2 h. Cultured cells were labeled with anti-CD8 and anti-CXCR3, followed by fixation, permeabilization, and intracellular cytokine labeling with anti-IFN-γ.

Graft-versus-host disease model
-------------------------------

Recipient BALB/c mice were exposed to 800 rad of total body irradiation from a \[^137^Cs\] source. Donor cells were prepared from the spleen of B6 mice injected with IL-4C daily for 7 days. CD8 T cells were selected by magnetic sorting (MACS; Miltenyi Biotec, Auburn, CA, USA), followed by sorting into CD44^low^CXCR3 ^+^ and CD44^hi^CXCR3 ^+^ cell populations using a FACSAria (BD Bioscience, San Jose, CA, USA) and CTV labeling. Each recipient mouse received 2×10^5^ sorted cells mixed with 3×10^6^ T cell-depleted bone marrow cells from WT B6 mice. The splenocytes were analyzed 8 weeks later.

Statistical analyses
--------------------

All data were analyzed by a two-way ANOVA using the GraphPad Prism software (GraphPad Software, CA, USA). The bar graphs represent the mean±standard deviation (SD).

RESULTS
=======

Generation of IL-4-induced CXCR3 ^+^ CD8 T cells
------------------------------------------------

To compare the phenotype and function of Eomes ^+^ innate CD8 T cells and IL-4-induced memory-like T cells arising from peripheral tissues, CIITA^Tg^ mice, IL-4C-treated mice, and WT mice (control) were used. As previous reported ([@B9]), we found that the proportion and absolute number of fully matured CD24^low^ CD8 SP thymocytes increased in CIITA^Tg^ mice when compared to WT mice ([Fig. 1A](#F1){ref-type="fig"}), most of which exhibited a characteristic CD44^hi^CXCR3 ^+^ phenotype ([Fig. 1B](#F1){ref-type="fig"}). A substantial fraction of CD44^hi^ memory CD8 T cells in the spleen of WT mice also expressed CXCR3, and CD44^low^CXCR3 ^+^ CD8 T cell populations were also detected in low numbers ([Fig. 1B](#F1){ref-type="fig"}). To obtain the IL-4-induced memory-like T cells, B6 mice were injected with IL-4C daily for 7 days, and CD8 T cells were isolated from the thymus and spleen of mice on the eighth day. Consistent with a previous report ([@B13]), IL-4C treatment resulted in an increase in CD8 T cells ([Fig. 1A](#F1){ref-type="fig"}) and the accumulation of a CD44^low^CXCR3 ^+^ cell population ([Fig. 1B](#F1){ref-type="fig"}) in the spleen. Of note, the CXCR3 ^+^ CD8 SP cell population was also expanded in the thymus of IL-4C-treated mice ([Fig. 1B](#F1){ref-type="fig"}). This was associated with an approximate two-fold increase in the number of fully matured CD24^low^ CD8 SP thymocytes ([Fig. 1A](#F1){ref-type="fig"}). However, the IL-4C-induced accumulation of CXCR3 ^+^ CD8 T cells was also observed in the spleen of thymectomized mice ([Fig. 1C](#F1){ref-type="fig"}), indicating that peripheral accumulation of these cells was not a result of emigration from the thymus. The effect of the IL-4C treatment was also observed in a monoclonal TCR system. For this experiment, CD45.1 ^+^ OT-I mice, which have ovalbumin-specific monoclonal TCR CD8 T cells, were injected with IL-4C daily for 7 days. Similar to the polyclonal system, both CD44^hi^CXCR3 ^+^ and CD44^low^CXCR3 ^+^ OT-I cells were markedly increased in the spleen of the IL-4C-treated recipients ([Fig. 1D](#F1){ref-type="fig"}).

When other memory markers were examined, both CD44^hi^CXCR3 ^+^ and CD44^low^CXCR3 ^+^ cell populations from IL-4C-treated mice were found to have higher expression levels of both CD124 (IL-4 receptor α subunit) and Eomes, when compared to Eomes ^+^ innate CD8 T cells from CIITA^Tg^ mice and to naïve CD8 T cells from WT mice ([Fig. 2A](#F2){ref-type="fig"}). Moreover, CD44^low^CXCR3 ^+^ CD8 T cells expressed CD62L, which functions as a lymphoid tissue homing receptor, while CD44^hi^CXCR3 ^+^ cell populations contained both central memory (CD44^hi^CD62L ^+^ ) and effector memory (CD44^hi^CD62L ^-^ ) T cells ([Fig. 2B](#F2){ref-type="fig"}). When CD44^hi^CXCR3 ^+^ CD8 T cells were stimulated with PMA and ionomycin, the majority of cells immediately produced IFN-γ, whereas CD44^low^CXCR3 ^+^ CD8 T cells isolated from three different mice showed low IFN-γ production capacity ([Fig. 2C](#F2){ref-type="fig"}).

Next, we investigated whether IL-4-induced memorylike CD8 T cells arose from naïve T cells and/or accumuaccumulated via expansion of preexisting CD44^hi^CXCR3 ^+^ cells, most of which are known to be VM T cells ([@B15]). For this purpose, CD44^low^CXCR3 ^-^ (naïve) or CD44^hi^CXCR3 ^+^ CD8 T cells were adoptively transferred into B6 mice, followed by IL-4C treatment. Donor cells were isolated from the spleen of CD45.1 ^+^ B6 mice and labeled with CTV prior to the adoptive transfer. In these B6 mice, IL-4C treatment induced the proliferation (CTV^low^) of CD44^low^CXCR3 ^-^ and CD44^hi^CXCR3 ^+^ CD8 T cells, and simultaneously, caused the differentiation of naïve CD8 T cells into both CD44^low^CXCR3 ^+^ and CD44^hi^CXCR3 ^+^ cells during their proliferation ([Fig. 3](#F3){ref-type="fig"}). These results indicate that the IL-4C treatment is able to induce the generation of memory-like CD8 T cells from naïve CD8 T cells, as well as expand pre-existing CD44^hi^CXCR3 ^+^ cells.

Maintenance and maturation of IL-4-induced CXCR3 ^+^ CD8 T cells
----------------------------------------------------------------

To determine how long CXCR3 ^+^ CD8 T cells could be maintained after cessation of IL-4C treatment, peripheral blood mononuclear cells were analyzed for approximately 1 month post-treatment. In IL-4C-treated mice, the total CXCR3 ^+^ cell population reached its peak size on the eighth day after discontinuation of IL-4C treatment, and then gradually decreased over the follow-up period ([Fig. 4A](#F4){ref-type="fig"}). The decrease in the total CXCR3 ^+^ cell population was associated with a contraction in the CD44^low^ fraction. In contrast, the CD44^hi^ fraction slowly increased and eventually the majority of CXCR3 ^+^ CD8 T cells exhibited a CD44^hi^ phenotype (by the 29^th^ day) ([Fig. 4A](#F4){ref-type="fig"}). These results suggest that CD44^low^CXCR3 ^+^ CD8 T cells might represent a transient stage between cells with a CD44^low^CXCR3 ^-^ naïve and CD44^hi^CXCR3 ^+^ memory phenotype. We also measured Eomes expression levels in the CXCR3 ^+^ population during the follow-up period. As previously shown, IL-4C treatment significantly upregulated Eomes expression in CXCR3 ^+^ CD8 T cells; however, these levels rapidly declined after discontinuation of IL-4C treatment, until basal levels were reached ([Fig. 4B](#F4){ref-type="fig"}).

Next, CD44^low^CXCR3 ^+^ or CD44^hi^CXCR3 ^+^ CD8 T cells isolated from the spleen of IL-4C-treated B6 mice were injected into sub-lethally irradiated BALB/c mice. Donor cells were labeled with CTV prior to the adoptive transfer for tracing. After the adoptive transfer of CD8 T cells, recipients of CD44^hi^CXCR3 ^+^ CD8 T cells showed a more severe reduction in body weight compared to that of the mice receiving CD44^low^CXCR3 ^+^ cells, indicating that CD44^hi^CXCR3 ^+^ cells have higher alloreactivity than CD44^low^CXCR3 ^+^ cells ([Fig. 4C](#F4){ref-type="fig"}). The injected cells were recovered 14 days after the transfer, and the population of proliferated CTV^low^ cells was gated. Some CD44^hi^CXCR3 ^+^ donor cells maintained their phenotype in terms of CD44 and CXCR3 expression levels, even 2 weeks after the stimulation with alloantigen; however, CXCR3 expression was downregulated in the main fraction ([Fig. 4D](#F4){ref-type="fig"}). CD44 expression was upregulated in almost all CD44^low^CXCR3 ^+^ donor cells, and their phenotype was nearly identical to that of activated CD44^hi^CXCR3 ^+^ donor cells. These data indicate that CD44^low^CXCR3 ^+^ CD8 T cells are converted into CD44^hi^CXCR3 ^+^ cells via TCR stimulation.

DISCUSSION
==========

IL-4 is a common γ chain cytokine that promotes differentiation of naïve CD4 ^+^ T cells into the Th2 cell subset and inhibits the Th1 response ([@B16][@B17]). IL-4 is also able to regulate CD8 T cell development and function. Endogenous IL-4 stimulates CD8 T cell proliferation ([@B14]); in the thymus, IL-4 is required for the development of innate CD8 T cells ([@B3]^69^). In addition, exogenous IL-4 induces a memory-like phenotype in peripheral CD8 T cells ([@B13]). In the present study, an exogenous IL-4 treatment upregulated CD44, CXCR3, CD124, and Eomes in peripheral CD8 T cells. Consistent with a previous report ([@B13]), IL-4 was more potent at causing the accumulation of CD44^low^CXCR3 ^+^ cells than the accumulation of CD44^hi^CXCR3 ^+^ CD8 T cells. This effect could be associated with the expansion of CD44^low^CXCR3 ^+^ cells and/or the conversion of naïve CD8 T cells to the CD44^low^CXCR3 ^+^ phenotype. In WT mice, CD44^low^CXCR3 ^+^ cells are rare relative to CD44^low^CXCR3 ^-^ naïve and CD44^hi^CXCR3 ^+^ memory cell populations. However, this cell population had higher CD124 (α chain of the IL-4 receptor) expression levels than CD44^hi^CXCR3 ^+^ cells, suggesting that the CD44^low^CXCR3 ^+^ cell population could be more susceptible to IL-4C treatment. Moreover, these cells could be generated from naïve CD8 T cells. In the spleen, the amount of CD44^low^CXCR3 ^-^ naïve T cells decreased after IL-4C treatment, suggesting that naïve T cells were converted to the CXCR3 ^+^ phenotype. This was confirmed by adoptive transfer of naïve CD8 T cells into congenic mice, followed by IL-4C treatment.

After cessation of IL-4C treatment, the total CXCR3 ^+^ cell population gradually decreased over a 1-month period. However, CD44 expression levels gradually increased in these cells, and the majority of CXCR3 ^+^ CD8 T cells exhibited the CD44^hi^ phenotype at the end of the follow-up period. CD44 expression levels in T cells increased as a result of diverse situations involving TCR signaling, like positive selection of thymocytes, homeostatic proliferation of T cells in a lymphopenic host, and activation by agonistic antigens. In the present study, a graft-versus-host disease model revealed that activation with an alloantigen promoted the differentiation of IL-4C-induced CD44^low^CXCR3 ^+^ CD8 T cells into CD44^hi^CXCR3 ^-^ and CD44^hi^CXCR3 ^+^ effector/memory cells. In the absence of exogenous antigen stimulation, TCR signaling by low affinity self-antigens seemed to upregulate CD44 expression levels in CXCR3 ^+^ CD8 T cells. This conversion of CD44^low^CXCR3 ^+^ cells to CD44^hi^CXCR3 ^+^ cells was associated with the acquisition of an enhanced effector function. CD44^hi^CXCR3 ^+^ cells produced significantly higher amounts of IFN-γ and exhibited higher alloreactivity than CD44^low^CXCR3 ^+^ cells. Moreover, CD44^low^CXCR3 ^+^ CD8 T cells expressed CD62L like naïve T cells, whereas CD44^hi^CXCR3 ^+^ populations contained both central memory (CD44^hi^CD62L ^+^ ) and effector memory (CD44^hi^CD62L ^-^ ) T cells. In this aspect, this step represents a maturation process.

In the present study, most splenic CD8 T cells from IL-4C-treated mice showed higher levels of CD124 expression when compared to untreated CD8 T cells. This reflects the fact that most CD8 T cells received an IL-4C-induced stimulation signal. However, CXCR3 expression was not upregulated in some of the CD8 T cells. Moreover, when CD8 T cells were treated with IL-4C *in vitro*, CXCR3 was not upregulated (data not shown). As proposed in a previous report ([@B18]), this result suggests that other signals are required for a full innate CD8 T cell-like phenotype.

Eomes expression levels significantly increased in CD8 T cells of IL-4C-treated mice, particularly in the CXCR3 ^+^ cell populations. However, after the IL-4C treatment was discontinued, Eomes expression levels in these cell populations gradually decreased. Similarly, although CIITA^Tg^ mice had abundant Eomes ^+^ CD44^hi^CXCR3 ^+^ innate CD8 T cells in their thymus ([@B9]), CD44^hi^CXCR3 ^+^ CD8 T cells from the spleen of these mice expressed only slightly higher levels of Eomes than their WT counterparts. Taken together, the results from this study suggest that IL-4 is required for the expression and maintenance of high-expressing Eomes in both centrally IL-4-induced innate CD8 T cells and peripherally IL-4-induced memory-like CD8 T cells.

Innate CD8 T cells are functionally characterized by enhanced INF-γ production and cytotoxic activity. Additionally, they could provide effective immune protection against intracellular organisms such as virus and bacteria ([@B7][@B19]). Based on this, we are now investigating whether IL-4C treatment could enhance antiviral immunity via generation and/or expansion of memory-like CD8 T cells.

This study conclusively demonstrated that IL-4-induced memory-like CD8 T cells that are generated in the peripheral tissues are very similar to innate CD8 T cells generated in the thymus in terms of phenotype, cytokine production, and IL-4 dependence for the maintenance of Eomes. These memory-like CD8 T cells can be generated from naïve CD8 T cells and can also be accumulated via the expansion of pre-existing VM CD8 T cells.
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![Generation of a memory-like CD8 T cell population by IL-4 and anti-IL-4 antibody complex injections. (A & B) Comparison of memory-like CD8 T cells in CIITA-transgenic (CIITA^Tg^) mice and IL-4C treated B6 mice. WT B6 mice were injected with IL-4C daily for 7 days. On day 8, CD4 and CD8 T cell populations among CD24^low^ mature thymocytes and total splenocytes (A) and the expression levels of CD44 and CXCR3 on CD8 T cells from the thymus and spleen (B) were compared with those of WT and CIITA^Tg^ mice. Representative flow cytometry data (left panel) and summarized graph (n=3, right panel) from two independent experiments are shown. Numbers in the plots indicate the percentages of cells in each quadrant. The bars represent mean±SD. ^\*^p\<0.05; ^\*\*^p\<0.01; ^\*\*\*^p \<0.001. (C) Thymus-independent accumulation of memory-like CD8 T cells in IL-4C-treated mice. WT and thymectomized B6 mice were injected with IL-4C daily for 7 days. CD8 T cells were isolated from the spleen to compare CD44 and CXCR3 expression levels with those of untreated mice. Representative flow cytometry data from two independent experiments are shown. Numbers in the plots indicate the percentages of cells in each quadrant. (D) Generation of memory-like CD8 T cells in monoclonal TCR transgenic mice. OT-1 TCR transgenic mice were treated with IL-4C for 7 days. CD8 T cells were isolated from the spleen, and then labeled with anti-CD44 and anti-CXCR3 antibodies. Representative flow cytometry data from three independent experiments are shown. Numbers in the plots indicate the percentages of cells in each quadrant.](in-16-126-g001){#F1}

![Phenotype and function of memory-like CD8 T cells in IL-4C-treated mice. Splenic CD8 T cells were isolated from IL-4C-treated mice, and the expression levels of the indicated markers (A & B) or IFN-γ production (C) were compared with those of CIITA-transgenic (CIITA^Tg^) and untreated WT mice. Summarized graph (n=3, A) and representative data from three independent experiments (B & C) are shown. The bars represent mean±SD. Numbers in the plots indicate the percentages of cells producing IFN-γ. ^\*^p\< 0.05; ^\*\*\*^p\<0.001.](in-16-126-g002){#F2}

![Generation of memory-like CD8 T cells from naïve CD8 T cells CD44^hi^CXCR3 ^+^ (memory phenotype) and CD44^low^CXCR3 ^-^ (naïve) cells sorted from CD45.1 ^+^ B6 splenocytes were labeled with CTV and transferred into CD45.2 ^+^ B6 mice via intravenous injection. The recipient mice were injected with IL-4C. The phenotypic changes and proliferation of transferred CD8 T cells in the spleen were analyzed. Numbers in the plots indicate the percentages of cells in each population or quadrant.](in-16-126-g003){#F3}

![Conversion of CD44^low^CXCR3 ^+^ CD8 T cells to the CD44^hi^ phenotype. (A & B) Effect that discontinuing IL-4C treatment has on the CXCR3 ^+^ CD8 T cell population. B6 mice were treated with IL-4C for 7 days, and the percentage of total CXCR3 ^+^ , CD44^hi^CXCR3 ^+^ , and CD44^low^CXCR3 ^+^ cell populations in peripheral blood CD8 T cells (A) and Eomes expression levels in CXCR3 ^+^ CD8 T cells (B) were analyzed by flow cytometry on the indicated days after treatment. Data summarized from two experiments are shown. (C & D) Conversion of CD44^low^CXCR3 ^+^ CD8 T cells to the CD44^hi^ phenotype by allo-stimulation. Splenic CD8 T cells from IL-4C-treated B6 mice were sorted into CD44^hi^CXCR3 ^+^ and CD44^low^CXCR3 ^+^ populations by FACSAria and labeled with CTV. A total of 2×10^5^ CTV-labeled cells from each population were mixed with 3×10^6^ T cell-depleted bone marrow cells from untreated B6 mice, and transferred into irradiated BALB/c mice through intravenous injection. After the transfer, body weight was monitored every week (C). On day 14 after the cell transfer, splenocytes from the recipient BALB/c mice were labeled with antibodies against H-2K^b^, CD8, CD44 and CXCR3, and the expression levels of CD44 and CXCR3 in CTV^low^ H-2K^b+^ donor CD8 T cells that had proliferated were analyzed by flow cytometry (D). Numbers in the plots indicate the percentage of cells in each quadrant.](in-16-126-g004){#F4}
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